跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Estrogen/Progestogen
首页
药物
Estrogen/Progestogen
Estrogen/Progestogen
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Pyridine imidazoles and aza-indoles as progesterone receptor modulators
US 7348432 B2
申请人: JANSSEN PHAMACEUTICA N V
优先权: 2005
CN
EP
US
7 件公开
Hormone containing emulsion
US 9789122 B2
申请人: BRAUN MELSUNGEN AG
优先权: 2012
CN
US
6 件公开
Spiro-benzo[c]chromene derivatives useful as modulators of the estrogen receptors
US 7452914 B2
申请人: JANSSEN PHARMACEUTICA NV
优先权: 2004
CN
US
4 件公开
PHARMACEUTICAL ASSOCIATION FOR TREATING AND/OR PREVENTING MYOMA AND/OR ENDOMETRIOSIS, USE OF RESVERATROL AND PROGESTOGEN, PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING MYOMA AND/OR ENDOMETRIOSIS, MEDICAMENT FOR TREATING AND/OR PREVENTING MYOMA AND/OR ENDOMETRIOSIS, KIT AND METHOD FOR TREATING AND/OR PREVENTING MYOMA AND/OR ENDOMETRIOSIS
EP 2617425 A4
申请人: LIBBS FARMACEUTICA LTDA
优先权: 2010
EP
US
4 件公开
Extended cycle multiphasic oral contraceptive method
US 7569560 B2
申请人: WARNER CHILCOTT CO LLC
优先权: 2005
US
4 件公开
US 8063030 B2
申请人: ELLMAN HERMAN
优先权: 2007
US
2 件公开
CN 101394845 A
申请人: WARNER CHILCOTT CO INC
优先权: 2006
CN
Pharmaceutical composition containing a tetrahydrofolic acid
US 8617597 B2
申请人: KING KRISTINA
优先权: 2007
US
4 件公开
CN 101484143 B
申请人: BAYER SCHERING PHARMA AG
优先权: 2007
CN
ESTRATRIENE DERIVATIVES COMPRISING HETEROCYCLIC BIOISOSTERES FOR THE PHENOLIC A-RING
US 2011190246 A1
申请人: BAYER SCHERING PHARMA AG
优先权: 2008
CN
EP
US
3 件公开
Heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators
US 7329654 B2
申请人: JANSSEN PHARMACEUTICA NV
优先权: 2002
CN
US
3 件公开
US 7105679 B2
申请人: KANOJIA RAMESH M
优先权: 2003
US
2 件公开
Progestogen-anti-progestogen regimens
US 6506390 B2
申请人: AKZO NOBEL
优先权: 2001
US
3 件公开
Heterocyclic benzo[c]chromene derivatives useful as modulators of the estrogen receptors
US 7399767 B2
申请人: ORTHO MCNEIL PHARM INC
优先权: 2006
US
3 件公开
第 1 / 5 页
上一页
下一页
药物
反馈